<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://jmedicalcasereports.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Medical Case Reports - Latest Articles</title>
        <link>http://www.jmedicalcasereports.com</link>
        <description>The latest research articles published by Journal of Medical Case Reports</description>
        <dc:date>2010-03-19T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/92" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/91" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/90" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/89" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/88" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/87" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/86" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/85" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/84" />
                                <rdf:li rdf:resource="http://www.jmedicalcasereports.com/content/4/1/83" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/92">
        <title>Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report</title>
        <description>IntroductionVascular malformation is associated with coagulopathies, especially when hemostasis is challenged.Case presentationWe present the case of an 11-year-old Hispanic girl with Klippel-Trenaunay-Weber syndrome that developed disseminated intravascular coagulation after minor surgery, which was controlled by blood product transfusions and enoxaparin to address an ongoing consumptive coagulopathy. The patient, however, developed bacteremia and liver trauma that resulted in severe bleeding. To the best of our knowledge, we report here the first known instance of administering recombinant coagulation factor VIIa to control acute bleeding in a patient with Klippel-Trenaunay-Weber syndrome.
Conclusions:
This case illustrates the concept of enoxaparin maintenance to suppress an ongoing consumptive coagulopathy and the use of recombinant coagulation factor VIIa to control its potentially fatal severe bleeding episodes.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/92</link>
                <dc:creator>Ulf Beier</dc:creator>
                <dc:creator>Mary Lou Schmidt</dc:creator>
                <dc:creator>Howard Hast</dc:creator>
                <dc:creator>Susan Kecskes</dc:creator>
                <dc:creator>Leonard Valentino</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:92</dc:source>
        <dc:date>2010-03-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-92</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>92</prism:startingPage>
        <prism:publicationDate>2010-03-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/91">
        <title>Involvement of the genicular branches in cystic adventitial disease of the popliteal artery as a possible marker of unfavourable early clinical outcome: a case report</title>
        <description>IntroductionCystic adventitial disease of the popliteal artery is a rare cause of non-atheromatous claudication. It usually requires surgery to improve the distance walked by patients.Case presentationWe report the case of a 44-year-old Caucasian man with unilateral symptomatic popliteal cysts extending to his genicular branches and associated with multilevel stenosis of his anterior tibial artery. A surgical evacuation of the cysts successfully restored his arterial patency and led to an objective haemodynamic improvement but was associated with early recurrence of symptoms.
Conclusion:
We suggest that the involvement of the genicular branches in cystic adventitial disease of the popliteal artery is a possible indicator of extensive adventitial degeneration and unfavourable clinical prognosis.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/91</link>
                <dc:creator>Efthymios Ypsilantis</dc:creator>
                <dc:creator>Paul Tisi</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:91</dc:source>
        <dc:date>2010-03-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-91</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>91</prism:startingPage>
        <prism:publicationDate>2010-03-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/90">
        <title>Late presentation of a mucinous ovarian adenocarcinoma which was initially diagnosed as a primary pancreatic carcinoma: a case report and review of the literature</title>
        <description>Introduction Adenocarcinoma of the ovary is an aggressive neoplasm which often metastasizes to the lung or liver. Metastases rarely occur to the pancreas, but a tissue diagnosis is required to confirm this event. Although most tumors of the pancreas are primary pancreatic neoplasms, metastatic lesions have been reported most commonly as arising from renal cell carcinoma.Case presentation We report the case of a 51-year-old Caucasian woman with ovarian mucinous adenocarcinoma with metastasis to the head of the pancreas that was originally misdiagnosed as a pancreatic primary tumor.Conclusion Mucinous ovarian adenocarcinomas rarely metastasize to the pancreas.  New pancreatic lesions should be investigated through tissue biopsy and tumor markers, while keeping an open-minded differential diagnosis to avoid a misdiagnosis or a delay in treatment.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/90</link>
                <dc:creator>Dorothy Sparks</dc:creator>
                <dc:creator>Daniel Chase</dc:creator>
                <dc:creator>Mark Forsyth</dc:creator>
                <dc:creator>Gregg Bogen</dc:creator>
                <dc:creator>Jon Arnott</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:90</dc:source>
        <dc:date>2010-03-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-90</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>90</prism:startingPage>
        <prism:publicationDate>2010-03-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/89">
        <title>Reduced uptake of the proliferation-seeking radiotracer technetium-99m-labelled pentavalent dimercaptosuccinic acid in a 47-year-old woman with severe breast epithelial hyperplasia taking ibuprofen: a case report</title>
        <description>IntroductionRecent studies have reported a risk reduction in the progression of benign breast disease to breast carcinoma through COX-2 pathways.Case presentationWe present a case of severe epithelial hyperplasia in a 47-year-old woman with increased breast density submitted to scintimammography by the proliferation-imaging tracer Technetium-99m-labelled pentavalent dimercaptosuccinic acid, before and after oral ibuprofen treatment for 4 weeks. The radiotracer uptake after ibuprofen intake was significantly reduced, both visually and by semi-quantitative analysis, based on  calculation of lesion-to-background ratios.
Conclusion:
In proliferating breast lesions, scintigraphically displayed reduction in Technetium-99m-labelled pentavalent dimercaptosuccinic acid uptake may indicate inhibition by ibuprofen in the pathway of malignant epithelial cell transformation.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/89</link>
                <dc:creator>Vassilios Papantoniou</dc:creator>
                <dc:creator>Evangelia Sotiropoulou</dc:creator>
                <dc:creator>Pipitsa Valsamaki</dc:creator>
                <dc:creator>Angeliki Tsaroucha</dc:creator>
                <dc:creator>Maria Sotiropoulou</dc:creator>
                <dc:creator>Nikolaos Ptohis</dc:creator>
                <dc:creator>Aikaterini Stipsanelli</dc:creator>
                <dc:creator>Konstantinos Dimitrakakis</dc:creator>
                <dc:creator>Spyridon Marinopoulos</dc:creator>
                <dc:creator>Spyridon Tsiouris</dc:creator>
                <dc:creator>Aris Antsaklis</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:89</dc:source>
        <dc:date>2010-03-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-89</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>89</prism:startingPage>
        <prism:publicationDate>2010-03-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/88">
        <title>Primary vaginal Ewing&apos;s sarcoma or primitive neuroectodermal tumor in a 17-year-old woman: a case report</title>
        <description>IntroductionPrimary Ewing&apos;s sarcoma or primitive neuroectodermal tumor of the genital tract of women is uncommon. Rarer still is its occurrence in the vagina, with only five cases described so far. Out of these, only one case was confirmed using molecular analysis.Case presentationWe present an extremely rare case of Ewing&apos;s sarcoma or primitive neuroectodermal tumor in a 17-year-old Indian girl. She presented with a vaginal mass that was initially diagnosed as a malignant round cell tumor. Immunohistochemistry showed diffuse positivity for vimentin, membranous positivity for MIC2, and positive for BCL2 and FLI-1. On the other hand, she was negative for cytokeratin, epithelial membrane antigen, desmin, Myo D-1, myogenin and smooth muscle actin. A diagnosis of primitive neuroectodermal tumor was thus offered. Furthermore, a molecular analysis of our patient using reverse transcription-polymerase chain reaction technique showed positivity for t(11; 22) (q24; q12) (EWSR1-FLI1), thus confirming the diagnosis of a Ewing&apos;s sarcoma/ primitive neuroectodermal tumor. Our patient was offered chemotherapy on Institutional protocol EFT 20001.
Conclusion:
This is a rare case of primary vaginal Ewing&apos;s sarcoma or primitive neuroectodermal tumor, which was confirmed with molecular analysis, in the youngest patient known so far. This study reinforces the value of integrating morphological features with membranous MIC2 positivity, along with application of molecular techniques in objective identification of an Ewing&apos;s sarcoma or primitive neuroectodermal tumor at uncommon sites.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/88</link>
                <dc:creator>Bharat Rekhi</dc:creator>
                <dc:creator>Sajid Qureshi</dc:creator>
                <dc:creator>Ranjan Basak</dc:creator>
                <dc:creator>Sangeeta Desai</dc:creator>
                <dc:creator>Seema Medhi</dc:creator>
                <dc:creator>Purna Kurkure</dc:creator>
                <dc:creator>Santosh Menon</dc:creator>
                <dc:creator>Amita Maheshwari</dc:creator>
                <dc:creator>Nirmala Jambhekar</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:88</dc:source>
        <dc:date>2010-03-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-88</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>88</prism:startingPage>
        <prism:publicationDate>2010-03-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/87">
        <title>Spontaneous dissection of the superior mesenteric artery and the right hepatic artery: a case report</title>
        <description>IntroductionIsolated spontaneous dissection of the superior mesenteric artery is a very rare condition. Endovascular stent placement has been proposed recently for selected cases, which has led to some good clinical results.Case presentationWe report a case of spontaneous dissection of the superior mesenteric artery spreading to the origin of a right hepatic artery in a 48-year-old Chinese man. He benefited from the placement of an endovascular stent that yielded excellent results.
Conclusion:
Endovascular stent placement is a good alternative treatment for dissection of the superior mesenteric artery. We propose an algorithm for the management of this rare condition.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/87</link>
                <dc:creator>Nicolas Buchs</dc:creator>
                <dc:creator>Pierre Charbonnet</dc:creator>
                <dc:creator>Frank Schwenter</dc:creator>
                <dc:creator>Cristoph Becker</dc:creator>
                <dc:creator>Philippe Morel</dc:creator>
                <dc:creator>Sylvain Terraz</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:87</dc:source>
        <dc:date>2010-03-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-87</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>87</prism:startingPage>
        <prism:publicationDate>2010-03-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/86">
        <title>Pica in iron deficiency: a case series</title>
        <description>IntroductionPica is an unusual condition where patients develop cravings for non-nutritive substances that can cause significant health risks. We report three patients with pica, two of them showing evolutionary changes associated with pica and the third demonstrating a peculiar nature of pica, which has yet to be reported.Case presentationWe describe three patients who presented with symptoms of pica. The first patient is a 36-year-old Caucasian woman who had dysfunctional uterine bleeding due to daily ingestion of two super-sized cups of ice as iced tea. The second patient is a 62-year-old Caucasian man who presented with bleeding from colonic polyps after drinking partially frozen bottled water. Lastly, the third patient, a 37-year-old Hispanic woman, presented with dysfunctional uterine bleeding after chewing rubber bands. All three patients presented with hematological parameters diagnostic for iron deficiency anemia.
Conclusion:
Pica has been practiced for centuries without a clear etiology. We have noticed that the younger community of academic and community physicians are not aware of the importance of complaints related to pica. None of our patients we describe here, as well as their primary care physicians, was aware of the importance of their pica related symptoms.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/86</link>
                <dc:creator>Yasir Khan</dc:creator>
                <dc:creator>Glenn Tisman</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:86</dc:source>
        <dc:date>2010-03-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-86</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>86</prism:startingPage>
        <prism:publicationDate>2010-03-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/85">
        <title>Primary treatment of acromegaly with high-dose lanreotide: a case series</title>
        <description>IntroductionThe first-line treatment for acromegaly is transsphenoidal surgery. In approximately 50% of patients, however, a cure is not possible with surgery and alternatives are needed. Somatostatin analog therapy is the recommended first-line treatment in patients with such cases. Here we provide the first report of a high-dose lanreotide primary therapy in patients with acromegaly.Case presentationSix patients who were not suitable for surgery were given 60mg of lanreotide (Autogel(R)) every four weeks. All patients were German nationals and Caucasian.When the response of our patients was unsatisfactory, the dose was increased sequentially to 90mg every four weeks, 120mg every four weeks, 120mg every three weeks and 180mg every three weeks. Treatment duration was 12 to 24 months. In all cases, the lanreotide dose was 120mg every 4 weeks or higher. In five of our patients, growth hormone (GH) levels were successfully reduced (in three patients GH &lt;2.5ng/ml was achieved). Insulin-like growth factor 1 levels were normalized in three patients and decreased in two patients. One patient failed to show a biochemical response to lanreotide therapy or pegvisomant therapy.Tumor shrinkage or degeneration was observed in the five responding patients. No drug-related adverse events were noted.
Conclusions:
These results suggest that lanreotide at high doses of 120mg every four weeks or more is an effective first-line therapy for patients with acromegaly that surgery alone cannot treat.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/85</link>
                <dc:creator>Christian Wuster</dc:creator>
                <dc:creator>Stefan Both</dc:creator>
                <dc:creator>Uwe Cordes</dc:creator>
                <dc:creator>Wael Omran</dc:creator>
                <dc:creator>Robert Reisch</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:85</dc:source>
        <dc:date>2010-03-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-85</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>85</prism:startingPage>
        <prism:publicationDate>2010-03-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/84">
        <title>Nocardia farcinica lung infection in a patient with cystic fibrosis: a case report</title>
        <description>IntroductionRespiratory tract infections are the major causes of morbidity and mortality in patients with cystic fibrosis. Nocardia are rarely implicated in these infections and few reports of the involvement of this species are found in the literature.Case presentationWe describe a case of lung infection followed by chronic colonization of trimethoprim and sulfamethoxazole resistant Nocardia farcinica in a patient with cystic fibrosis. The chronic colonization of this uncommon bacterium in patients with cystic fibrosis was proved using a newly developed real-time polymerase chain reaction assay, which indicates that this bacterium, despite treatment, is difficult to eradicate.
Conclusion:
Our case report confirms that this organism can be recovered in persons with cystic fibrosis. Its eradication is necessary especially if the patient is to undergo lung transplantation.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/84</link>
                <dc:creator>Fadi Bittar</dc:creator>
                <dc:creator>Nathalie Stremler</dc:creator>
                <dc:creator>Jean-Pierre Audie</dc:creator>
                <dc:creator>Jean-Christophe Dubus</dc:creator>
                <dc:creator>Jacques Sarles</dc:creator>
                <dc:creator>Didier Raoult</dc:creator>
                <dc:creator>Jean-Marc Rolain</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:84</dc:source>
        <dc:date>2010-03-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-84</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>84</prism:startingPage>
        <prism:publicationDate>2010-03-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jmedicalcasereports.com/content/4/1/83">
        <title>Endoscopic management of biliary fascioliasis: a case report</title>
        <description>IntroductionFasciola hepatica, an endemic parasite common in Iraq and its neighboring countries, is a very rare cause of cholestasis worldwide. Humans can become definitive hosts of this parasite through their ingestion of a contaminated water plant, for example, contaminated watercress. Symptoms of cholestasis may appear suddenly and, in some cases, are preceded by long periods of fever, eosinophilia, and vague gastrointestinal symptoms. Here we report the case of a woman with a sudden onset of symptoms of cholangitis. Her infection was proved by endoscopic retrograde cholangiography to be due to Fasciola hepatica infestation.Case presentationA 38-year-old Kurdish woman from the northern region of Iraq presented with fever, right upper quadrant abdominal pain, and jaundice. An examination of the patient revealed elevated total serum bilirubin and liver enzymes. An ultrasonography also showed a dilatation of her common bile duct. During endoscopic retrograde cholangiopancreatography, a filling defect was identified in her common bile duct. After sphincterotomy and balloon extraction, one live Fasiola hepatica was extracted and physically removed.
Conclusion:
Fasciola hepatica should be a part of the differential diagnosis of common bile duct obstruction. When endoscopic retrograde cholangiopancreatography is available, the disease can be easily diagnosed and treated.</description>
        <link>http://www.jmedicalcasereports.com/content/4/1/83</link>
                <dc:creator>Rajan Ezzat</dc:creator>
                <dc:creator>Taha Karboli</dc:creator>
                <dc:creator>Kalandar Kasnazani</dc:creator>
                <dc:creator>Adnan Hamwandi</dc:creator>
                <dc:source>Journal of Medical Case Reports 2010, 4:83</dc:source>
        <dc:date>2010-03-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1752-1947-4-83</dc:identifier>
        <prism:publicationName>Journal of Medical Case Reports</prism:publicationName>
        <prism:issn>1752-1947</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>83</prism:startingPage>
        <prism:publicationDate>2010-03-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
